Sexual Dysfunction in Women With Multiple Sclerosis (MS)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-16

Study Completion Date

2025-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Sexual dysfunction in women with multiple sclerosis (MS) is an important yet often overlooked problem. The primary objective of this study is to investigate the prevalence of sexual dysfunction in female patients diagnosed with MS. The secondary objective is to evaluate the relationship between sexual dysfunction and fatigue, depression, anxiety, overactive bladder symptoms, and cognitive dysfunction.

For this purpose, the following validated instruments will be used: the Female Sexual Function Index (FSFI) to assess sexual dysfunction, the Brief International Cognitive Assessment for MS (BICAMS) to evaluate cognitive function, the Hospital Anxiety and Depression Scale (HADS) to assess depression and anxiety, the Fatigue Severity Scale (FSS) to measure fatigue, and the Overactive Bladder Questionnaire (OAB-V8) to evaluate overactive bladder symptoms.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sexual Dysfunction in Patients With Relapsing Remitting Multiple Sclerosis and Associated Comorbidities

NCT04157283

Multiple Sclerosis Sexual Dysfunction

UNKNOWN

The Effect of Sexual Counseling With the PLISSIT Model on Sexual Function and Sexual Quality of Life in Women With Multiple Sclerosis: A Randomized Controlled Study

NCT06004518

Multiple Sclerosis Female Sexual Dysfunction

UNKNOWN NA

Follow-up of Persons With Multiple Sclerosis

NCT03878836

Multiple Sclerosis

UNKNOWN

Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)

NCT01080053

Multiple Sclerosis, Relapsing Remitting

COMPLETED

The Effect of Hope Placement Program on Dıagnosed Wıth MS

NCT05840653

Multiple Sclerosis

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis Multiple Sclerosis (MS) - Relapsing-remitting Fatigue in Multiple Sclerosis Sexual Disfunction Cognitive Dysfunction Depression Anxiety Overactive Bladder Fatigue

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female patients aged 25-50 years
* Literate and able to comprehend written and spoken instructions
* Diagnosed with relapsing-remitting form of multiple sclerosis
* Having a continuous/regular sexual partner
* Expanded Disability Status Scale (EDSS) score ≤ 5
* At least 3 months since the last relapse
* Sexually active within the past 3 months
* Spasticity level \< grade 2 according to the Modified Ashworth Scale

Exclusion Criteria

* Pregnancy
* Illiteracy or inability to understand spoken or written instructions
* Absence of a continuous/regular sexual partner
* Expanded Disability Status Scale (EDSS) score \> 5
* Not sexually active within the past 3 months
* Spasticity level ≥ grade 2 according to the Modified Ashworth Scale

Minimum Eligible Age

25 Years

Maximum Eligible Age

50 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No